Become A Featured Company

Medical Marijuana Inc. Continues to Expand International Reach

Ryan Allway

October 27th, 2017

Exclusive, News, Top News

The global hemp industry is projected to surpass $1 billion in revenue next year, according to the Hemp Business Journal, and hemp-based cannabidiol (CBD) is among the fastest growing segments with a 53% compound annual growth rate over the past several years.

Medical Marijuana Inc.’s (OTC Pink: MJNA) 100%-owned HempMeds®  subsidiary sells a full-spectrum, complete CBD hemp oil called Real Scientific Hemp Oil, or RSHO™. Starting with hemp grown in Northern Europe, the company produces the highest quality natural hemp oil in the industry with 10% to 30% CBD content. The tremendous success in growing this business has made it the second largest asset on MJNA’s balance sheet at $140 million.

Brazil Subsidizes RSHO™ for Citizen

Medical Marijuana Inc. recently announced that Brazilian Federal Judge Rogerio Favreto ordered the government to subsidize payments for RSHO™ for one of its citizens. This was the second recent case where a federal judge has ordered the government to subsidize payments for CBD in Santa Catarina, saying that CBD should be covered as a prescription pharmaceutical given its proven medical benefits.

According to an account by a Brazilian newspaper:

“The trader appealed to the court, arguing that the use of the drug is essential, that efficacy is proven in such cases and that the right to health is fundamental and guaranteed by the Constitution. The court’s rapporteur, federal judge Rogerio Favreto, stated in his vote that the interference of the judiciary in drug applications, even if it is an exception, should occur if the patient’s need is proven. The judge pointed out that in the case under analysis the urgency is evident and has been proven by medical expertise.”

Medical Marijuana Inc.’s RSHO™ has been a go-to hemp-based CBD product around the world. With the goal of bringing hemp oil to the masses, the company has sought out to make it easier for patients to petition governments while developing a product that meets the strictest standards to limit tetrahydrocannabinol (THC) content.

“We continue to be impressed and humbled by the amazing, historic gestures by the judicial system and federal government regulators in Brazil acting in the best interests of the health and wellness of the Brazilian people,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “This amazing progress in the Brazilian courts reaffirms our mission to keep educating the world about the beneficial nature of hemp-based cannabidiol (CBD) products such as RSHO™.”

Expanding Global Presence

Medical Marijuana Inc. has been making progress in marketing RSHO™ around the world, where it has been embraced by patients, doctors, and citizens.

The first breakthrough came in Brazil where the family of a little girl fought for the right to import RSHO™. After taking the case to the nation’s courts, it was declared “inhumane” to keep hemp oil from the girl and HempMeds® began shipping RSHO™ directly to patients in Brazil where it is now wholly subsidized through the nation’s healthcare system as a prescription medication. HempMeds® Brazil was setup to help patients navigate the complex regulations.

A similar situation unfolded in Mexico where Raul Elizalde discovered CBD hemp oil and its potential benefits for his daughter. He created the Por Grace Foundation and teamed up with HempMeds® to create awareness among patients. The nation’s health authority, COFEPRIS, ultimately approved the use of CBD under the condition that it has no THC content. To meet these requirements, the company developed THC-free RSHO-X™ and setup HempMeds Mexico.

The company has since expanded its product reach into several other regions and countries around the world, including Puerto Rico and parts of South America. In addition, the company has established a wholesale division that sells high quality hemp oil to third-party product manufacturers and marketers looking to expand their product lines.

Looking Ahead

Medical Marijuana Inc. (OTC Pink: MJNA) represents a compelling investment opportunity in the $1+ billion hemp industry. With its RSHO™ product line, the company has become a leading advocate for the health benefits of CBD around the world. This progress has cemented its leadership position in several countries, while it simultaneously pursues research collaborations that could further improve its product positioning.

For more information, visit the company’s website.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading